32.78
price down icon1.50%   -0.50
after-market 시간 외 거래: 32.78
loading

Veracyte Inc 주식(VCYT)의 최신 뉴스

pulisher
Mar 18, 2026

Does Veracyte (VCYT) offer both strength and opportunity? - MSN

Mar 18, 2026
pulisher
Mar 17, 2026

Breakouts Watch: Can Veracyte Inc expand into new marketsQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

How Veracyte’s New AI-Focused CTO Role At Veracyte (VCYT) Has Changed Its Investment Story - simplywall.st

Mar 17, 2026
pulisher
Mar 17, 2026

Veracyte appoints Kevin Haas as chief development officer - Investing.com India

Mar 17, 2026
pulisher
Mar 17, 2026

Veracyte appoints Kevin Haas as chief development officer By Investing.com - Investing.com South Africa

Mar 17, 2026
pulisher
Mar 16, 2026

Veracyte CFO Chambers sells $662k in VCYT stock - Investing.com Nigeria

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte (VCYT) Appoints New Chief Development and Technology Of - GuruFocus

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte names Kevin Haas as Chief Development and Technology Officer - TipRanks

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte names Kevin Haas as chief development and technology officer - marketscreener.com

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte Names Kevin Haas As Chief Development And Technology Officer - TradingView

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte Appoints Kevin Haas as Chief Technology Leader - TipRanks

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte Appoints Kevin Haas as Chief Development and Technology Officer - marketscreener.com

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte (NASDAQ: VCYT) hires Kevin Haas as Chief Development and Technology Officer - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte Names Kevin Haas as Chief Development and Technology Officer - The Joplin Globe

Mar 16, 2026
pulisher
Mar 16, 2026

Veracyte, Inc. Appoints Kevin Haas as Chief Development and Technology Officer, Effective March 24, 2026 - marketscreener.com

Mar 16, 2026
pulisher
Mar 16, 2026

Iron Triangle Partners LP Purchases New Position in Veracyte, Inc. $VCYT - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Fred Alger Management LLC Takes $26.35 Million Position in Veracyte, Inc. $VCYT - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Bamco Inc. NY Decreases Stake in Veracyte, Inc. $VCYT - MarketBeat

Mar 16, 2026
pulisher
Mar 15, 2026

Veracyte, Inc. $VCYT is ArrowMark Colorado Holdings LLC's 7th Largest Position - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

Veracyte Inc Stock (ISIN: US92347M1009) Holds Steady Amid Analyst Downgrade and Mixed Signals - AD HOC NEWS

Mar 14, 2026
pulisher
Mar 14, 2026

Veracyte (NASDAQ:VCYT) Downgraded by Zacks Research to "Hold" - MarketBeat

Mar 14, 2026
pulisher
Mar 12, 2026

Veracyte, Inc. $VCYT Stock Holdings Lifted by First Trust Advisors LP - MarketBeat

Mar 12, 2026
pulisher
Mar 10, 2026

Veracyte (VCYT) CAO awarded 10,525 RSUs in new equity grant - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Veracyte (NASDAQ: VCYT) SVP Annie McGuire receives new stock awards - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Veracyte (NASDAQ: VCYT) CCO granted new restricted stock units - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Veracyte (VCYT) grants CEO Marc Stapley 92,099 RSUs vesting from 2027 - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Veracyte (VCYT) CFO receives restricted stock unit grants boosting holdings - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Veracyte, Inc. (NASDAQ:VCYT) Q2 2025 Earnings Call Transcript - MSN

Mar 10, 2026
pulisher
Mar 09, 2026

Panic Selling: Can Veracyte Inc. ride the EV waveWeekly Trade Analysis & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn

Mar 09, 2026
pulisher
Mar 09, 2026

Veracyte at Leerink Global Healthcare: Strategic Growth Focus By Investing.com - Investing.com Canada

Mar 09, 2026
pulisher
Mar 08, 2026

Are Veracyte's (VCYT) Strong 2025 Profits and Reaffirmed 2026 Outlook Redefining Its Growth Story? - simplywall.st

Mar 08, 2026
pulisher
Mar 07, 2026

Veracyte CFO Chambers sells $662k in VCYT stock By Investing.com - Investing.com Canada

Mar 07, 2026
pulisher
Mar 06, 2026

Insider Sell: Rebecca Chambers Sells Shares of Veracyte Inc (VCY - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

UBS reaffirmed buy rating on Veracyte (VCYT) after strong Q4 testing revenue - MSN

Mar 06, 2026
pulisher
Mar 06, 2026

Veracyte (NASDAQ:VCYT) CFO Rebecca Chambers Sells 18,341 Shares - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Veracyte (VCYT) CFO executes Rule 10b5-1 stock sale - Stock Titan

Mar 06, 2026
pulisher
Mar 06, 2026

Veracyte (VCYT) CEO sells 45,523 shares under pre-set 10b5-1 plan - Stock Titan

Mar 06, 2026
pulisher
Mar 06, 2026

Veracyte (VCYT) CCO Leite sells 5,260 shares under Rule 10b5-1 plan - Stock Titan

Mar 06, 2026
pulisher
Mar 06, 2026

VCYT: Morgan Stanley Lowers Price Target Amidst Underweight Rati - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

Morgan Stanley Lowers Price Target on Veracyte to $37 From $48, Keeps Underweight Rating - marketscreener.com

Mar 06, 2026
pulisher
Mar 05, 2026

Morgan Stanley cuts Veracyte stock price target on valuation methodology By Investing.com - Investing.com Canada

Mar 05, 2026
pulisher
Mar 05, 2026

Morgan Stanley cuts Veracyte stock price target on valuation methodology - Investing.com

Mar 05, 2026
pulisher
Mar 05, 2026

Veracyte, Inc. $VCYT Shares Sold by GW&K Investment Management LLC - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Veracyte, Inc. $VCYT Shares Acquired by ARK Investment Management LLC - MarketBeat

Mar 05, 2026
pulisher
Mar 04, 2026

Affiliate to sell 6,658 Restricted Stock Units — VCYT (NASDAQ: VCYT) - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

[144] VERACYTE, INC. SEC Filing - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Marc Stapley (NASDAQ: VCYT) reports sale of 15,000 shares for $1.92M - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Veracyte Insider Sold Shares Worth $485,429, According to a Recent SEC Filing - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Veracyte (NASDAQ: VCYT) VP has 3,006 shares withheld for taxes - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Veracyte (VCYT) CFO reports 7,234-share tax withholding, not a sale - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Veracyte (VCYT) exec sells 13,425 shares, 117,346 remain - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Veracyte (VCYT) CEO has 19,455 shares withheld to cover taxes - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Segall Bryant & Hamill LLC Has $18.31 Million Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Champlain Investment Partners LLC Makes New $40.06 Million Investment in Veracyte, Inc. $VCYT - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

VCYT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Veracyte, Inc. (VCYT) Stock Analysis: Uncovering A Promising 34.96% Upside For Investors - DirectorsTalk Interviews

Mar 03, 2026
pulisher
Mar 03, 2026

William Blair Investment Management LLC Buys New Stake in Veracyte, Inc. $VCYT - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Veracyte (VCYT) Valuation Check After Strong 2025 Earnings And Reaffirmed 2026 Growth Outlook - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

JPMorgan Chase & Co. Has $17.81 Million Position in Veracyte, Inc. $VCYT - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire

Mar 03, 2026
pulisher
Mar 02, 2026

Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre - Investing.com South Africa

Mar 02, 2026
pulisher
Mar 02, 2026

Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre By Investing.com - Investing.com Nigeria

Mar 02, 2026
diagnostics_research DGX
$194.16
price down icon 0.55%
diagnostics_research LH
$264.09
price down icon 0.66%
diagnostics_research MTD
$1,190.49
price down icon 0.09%
diagnostics_research IQV
$166.47
price down icon 0.33%
$202.73
price up icon 2.50%
diagnostics_research WAT
$299.57
price up icon 1.53%
자본화:     |  볼륨(24시간):